APON(SZ:300753) Xin Lang Cai Jing·2025-09-18 06:57Company Overview - Aipeng Medical experienced a decline of 5.03% on September 18, with a stock price of 29.65 yuan per share, a trading volume of 230 million yuan, a turnover rate of 8.57%, and a total market capitalization of 3.737 billion yuan [1] Business Operations - Aipeng Medical, established on October 30, 2001, and listed on December 13, 2018, is located in the Jiangsu Province. The company specializes in the research, development, production, and sales of medical devices in the fields of pain management and nasal care [1] - The revenue composition of Aipeng Medical includes: 59.73% from pain management products, 29.40% from nasal and upper airway products, and 10.87% from other sources [1] Fund Holdings - According to data, Beixin Ruifeng Fund has one fund heavily invested in Aipeng Medical. The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) held 120,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest holding [2] - The fund has reported a floating loss of approximately 188,400 yuan as of the latest data [2] Fund Performance - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) was established on March 27, 2015, with a latest scale of 89.3779 million yuan. Year-to-date, it has achieved a return of 35.19%, ranking 2286 out of 8172 in its category. Over the past year, it has returned 70.92%, ranking 1705 out of 7980, and since inception, it has returned 28.7% [2]